Monday, October 26, 2026 · Daily editionET --:--:--

Not recruiting yet

Advanced Robotic Techniques and Rapid Onsite Evaluation for Minimally Invasive Diagnosis and Next-Generation Sequencing.

NCT07685977 · Vanderbilt University Medical Center · Updated 6 July 2026

What is being tested
Rapid onsite evaluation
For
Peripheral Pulmonary Lesions (PPLs)
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 400 people. The full rules are on the registry page.
Where
United States (8 sites)
When
Starts or started 1 Oct 2026, ends 1 April 2029. Registered 6 July 2026.
Results
None posted yet.

In the researchers' words

ARTEMIS is a multicenter randomized controlled trial. The goal is to understand whether rapid onsite evaluation during robotic assisted bronchoscopy improves the diagnostic performance of the procedure or not.
ClinicalTrials.gov, NCT07685977

Sites

  • Northwestern Memorial HospitalChicago, Illinois, United States
  • Rush University Medical CenterChicago, Illinois, United States
  • Johns Hopkins UniversityBaltimore, Maryland, United States
  • Lahey Hospital and Medical CenterBurlington, Massachusetts, United States
  • Memorial Sloan Kettering Cancer CenterNew York, New York, United States
  • University of North Carolina Medical CenterChapel Hill, North Carolina, United States
  • Medical University of South CarolinaCharleston, South Carolina, United States
  • Vanderbilt University Medical CenterNashville, Tennessee, United States